Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity
Alzheimer’s disease (AD) is a common neurodegenerative disease presenting with progressive memory and cognitive impairments. One of the pathogenic mechanisms of AD is attributed to the aggregation of misfolded amyloid β (Aβ), which induces neurotoxicity by reducing the expression of brain-derived ne...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/55f12e9aea6649f9b7d98415a9df3644 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:55f12e9aea6649f9b7d98415a9df3644 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:55f12e9aea6649f9b7d98415a9df36442021-11-25T17:11:26ZMulti-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity10.3390/cells101130952073-4409https://doaj.org/article/55f12e9aea6649f9b7d98415a9df36442021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3095https://doaj.org/toc/2073-4409Alzheimer’s disease (AD) is a common neurodegenerative disease presenting with progressive memory and cognitive impairments. One of the pathogenic mechanisms of AD is attributed to the aggregation of misfolded amyloid β (Aβ), which induces neurotoxicity by reducing the expression of brain-derived neurotrophic factor (BDNF) and its high-affinity receptor tropomyosin-related kinase B (TRKB) and increasing oxidative stress, caspase-1, and acetylcholinesterase (AChE) activities. Here, we have found the potential of two novel synthetic coumarin derivatives, ZN014 and ZN015, for the inhibition of Aβ and neuroprotection in SH-SY5Y neuroblastoma cell models for AD. In SH-SY5Y cells expressing the GFP-tagged Aβ-folding reporter, both ZN compounds reduced Aβ aggregation, oxidative stress, activities of caspase-1 and AChE, as well as increased neurite outgrowth. By activating TRKB-mediated extracellular signal-regulated kinase (ERK) and AKT serine/threonine kinase 1 (AKT) signaling, these two ZN compounds also upregulated the cAMP-response-element binding protein (CREB) and its downstream BDNF and anti-apoptotic B-cell lymphoma 2 (BCL2). Knockdown of TRKB attenuated the neuroprotective effects of ZN014 and ZN015. A parallel artificial membrane permeability assay showed that ZN014 and ZN015 could be characterized as blood–brain barrier permeable. Our results suggest ZN014 and ZN015 as novel therapeutic candidates for AD and demonstrate that ZN014 and ZN015 reduce Aβ neurotoxicity via pleiotropic mechanisms.Ching-Chia HuangKuo-Hsuan ChangYa-Jen ChiuYi-Ru ChenTsai-Hui LungHsiu Mei Hsieh-LiMing-Tsan SuYing-Chieh SunChiung-Mei ChenWenwei LinGuey-Jen Lee-ChenMDPI AGarticleAβAlzheimer’s diseasecoumarinsTRKB agonistneuroprotectiontherapeuticsBiology (General)QH301-705.5ENCells, Vol 10, Iss 3095, p 3095 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Aβ Alzheimer’s disease coumarins TRKB agonist neuroprotection therapeutics Biology (General) QH301-705.5 |
spellingShingle |
Aβ Alzheimer’s disease coumarins TRKB agonist neuroprotection therapeutics Biology (General) QH301-705.5 Ching-Chia Huang Kuo-Hsuan Chang Ya-Jen Chiu Yi-Ru Chen Tsai-Hui Lung Hsiu Mei Hsieh-Li Ming-Tsan Su Ying-Chieh Sun Chiung-Mei Chen Wenwei Lin Guey-Jen Lee-Chen Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity |
description |
Alzheimer’s disease (AD) is a common neurodegenerative disease presenting with progressive memory and cognitive impairments. One of the pathogenic mechanisms of AD is attributed to the aggregation of misfolded amyloid β (Aβ), which induces neurotoxicity by reducing the expression of brain-derived neurotrophic factor (BDNF) and its high-affinity receptor tropomyosin-related kinase B (TRKB) and increasing oxidative stress, caspase-1, and acetylcholinesterase (AChE) activities. Here, we have found the potential of two novel synthetic coumarin derivatives, ZN014 and ZN015, for the inhibition of Aβ and neuroprotection in SH-SY5Y neuroblastoma cell models for AD. In SH-SY5Y cells expressing the GFP-tagged Aβ-folding reporter, both ZN compounds reduced Aβ aggregation, oxidative stress, activities of caspase-1 and AChE, as well as increased neurite outgrowth. By activating TRKB-mediated extracellular signal-regulated kinase (ERK) and AKT serine/threonine kinase 1 (AKT) signaling, these two ZN compounds also upregulated the cAMP-response-element binding protein (CREB) and its downstream BDNF and anti-apoptotic B-cell lymphoma 2 (BCL2). Knockdown of TRKB attenuated the neuroprotective effects of ZN014 and ZN015. A parallel artificial membrane permeability assay showed that ZN014 and ZN015 could be characterized as blood–brain barrier permeable. Our results suggest ZN014 and ZN015 as novel therapeutic candidates for AD and demonstrate that ZN014 and ZN015 reduce Aβ neurotoxicity via pleiotropic mechanisms. |
format |
article |
author |
Ching-Chia Huang Kuo-Hsuan Chang Ya-Jen Chiu Yi-Ru Chen Tsai-Hui Lung Hsiu Mei Hsieh-Li Ming-Tsan Su Ying-Chieh Sun Chiung-Mei Chen Wenwei Lin Guey-Jen Lee-Chen |
author_facet |
Ching-Chia Huang Kuo-Hsuan Chang Ya-Jen Chiu Yi-Ru Chen Tsai-Hui Lung Hsiu Mei Hsieh-Li Ming-Tsan Su Ying-Chieh Sun Chiung-Mei Chen Wenwei Lin Guey-Jen Lee-Chen |
author_sort |
Ching-Chia Huang |
title |
Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity |
title_short |
Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity |
title_full |
Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity |
title_fullStr |
Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity |
title_full_unstemmed |
Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity |
title_sort |
multi-target effects of novel synthetic coumarin derivatives protecting aβ-gfp sh-sy5y cells against aβ toxicity |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/55f12e9aea6649f9b7d98415a9df3644 |
work_keys_str_mv |
AT chingchiahuang multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity AT kuohsuanchang multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity AT yajenchiu multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity AT yiruchen multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity AT tsaihuilung multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity AT hsiumeihsiehli multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity AT mingtsansu multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity AT yingchiehsun multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity AT chiungmeichen multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity AT wenweilin multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity AT gueyjenleechen multitargeteffectsofnovelsyntheticcoumarinderivativesprotectingabgfpshsy5ycellsagainstabtoxicity |
_version_ |
1718412650121003008 |